|
|
|
|
|
|
|
|
|
|
|
|
|
24.04.26 - 09:30
|
Trigger happy wiki-Trader Mate Gotovac: "Value und Charttechnik nach der Levermann-Strategie" (BRN)
|
|
|
wikifolio "Value und Charttechnik" von Trader Mate Gotovac: "Ich habe mein wikifolio jetzt darauf ausgerichtet, dass ich vorsichtiger bin. Volatilität nach oben ist immer schön, aber Volatilität in Summe ist für mich etwas, was mich persönlich auch ein bisschen beunruhigt. Mit Equinor und TotalEnergies befanden sich aber schon vor dem Iran-Krieg zwei Öl-Aktien im Depot. Bei der Auswahl seiner Werte schaut Trader Mate Gotovac auf Kennzahlen wie KGV und Cashflow. Die Levermann-Strategie (benannt nach der Volkswirtin Susan Levermann) spielt dabei eine große Rolle und basiert auf einer quantitativen Analyse-Methode. Weitere Werte: Talanx, Pfizer, IONOS, Kontron, Novo Nordisk, Sanofi, Comcast und Chubb. Der Cashanteil liegt bei fast 50 %. Mehr unter: https://www.wikifolio.com/de/de/p/mateg?tab=wikifolios...
|
|
|
|
|
|
|
22.04.26 - 22:48
|
Pfizer Declares Second-Quarter 2026 Dividend (Business Wire)
|
|
|
Board of Directors approves quarterly cash dividend of $0.43 per shareNEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2026 dividend on the company's common stock, payable June 12, 2026, to holders of the Common Stock of record at the close of business on May 8, 2026. The second-quarter 2026 cash dividend will be the 350th consecutive quarterly dividend paid by Pfizer.
About Pfizer: Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our resp...
|
|
|
|
|
|
|
|
|
21.04.26 - 12:24
|
Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy (PBR)
|
|
|
The application aims to allow the use of this combination therapy for all patients with MIBC, regardless of their cisplatin eligibility. It could potentially broaden the approved use,
The post Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
17.04.26 - 16:24
|
AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit (24/7 Wall St.)
|
|
|
AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net sales with revenue up 10% year over year, powered by a post-Humira immunology rebuild that is now clearly working. Pfizer posted a slight revenue decline of 1.16% while absorbing a massive COVID hangover and betting billions on obesity ... AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit...
|
|
|
16.04.26 - 14:00
|
Here Are Thursday′s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: The futures are trading modestly higher after a wild Wednesday that saw the Nasdaq explode higher to close at an all-time high of 24,016, up a hefty 1.60%, while the S&P 500 closed up 0.80% at 7,022, also hitting a brand-new all-time closing high. The small-cap Russell 2000, the leading index this ... Here Are Thursday's Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More...
|
|